| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.17 | 0.6 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |